MK-0472
/ Merck (MSD), Otsuka
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
May 28, 2024
Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001)
(clinicaltrials.gov)
- P1 | N=178 | Recruiting | Sponsor: Merck Sharp & Dohme LLC | N=100 ➔ 178
Enrollment change • Oncology • Solid Tumor
June 29, 2023
Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001)
(clinicaltrials.gov)
- P1 | N=100 | Recruiting | Sponsor: Merck Sharp & Dohme LLC | Not yet recruiting ➔ Recruiting
Combination therapy • Enrollment open • Metastases • Monotherapy • Oncology • Solid Tumor
May 10, 2023
Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001)
(clinicaltrials.gov)
- P1 | N=100 | Not yet recruiting | Sponsor: Merck Sharp & Dohme LLC
Combination therapy • Metastases • Monotherapy • New P1 trial • Oncology • Solid Tumor
1 to 3
Of
3
Go to page
1